57 related articles for article (PubMed ID: 20135670)
1. Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis.
Kunz M; Driller KM; Hein M; Libnow S; Hohensee I; Ramer R; Hinz B; Berger A; Eberle J; Langer P
ChemMedChem; 2010 Apr; 5(4):534-9. PubMed ID: 20135670
[No Abstract] [Full Text] [Related]
2. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of glycoside inhibitors of glioma and melanoma growth.
García-Alvarez I; Corrales G; Doncel-Pérez E; Muñoz A; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2007 Jan; 50(2):364-73. PubMed ID: 17228879
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of selenoindirubins and selenoindirubin-N-glycosides.
Erben F; Kleeblatt D; Sonneck M; Hein M; Feist H; Fahrenwaldt T; Fischer C; Matin A; Iqbal J; Plötz M; Eberle J; Langer P
Org Biomol Chem; 2013 Jun; 11(24):3963-78. PubMed ID: 23673975
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
6. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity of novel indirubin-5-carboxamides.
Cheng X; Rasqué P; Vatter S; Merz KH; Eisenbrand G
Bioorg Med Chem; 2010 Jun; 18(12):4509-15. PubMed ID: 20488718
[TBL] [Abstract][Full Text] [Related]
8. Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors.
Venkatesan AM; Dehnhardt CM; Chen Z; Santos ED; Dos Santos O; Bursavich M; Gilbert AM; Ellingboe JW; Ayral-Kaloustian S; Khafizova G; Brooijmans N; Mallon R; Hollander I; Feldberg L; Lucas J; Yu K; Gibbons J; Abraham R; Mansour TS
Bioorg Med Chem Lett; 2010 Jan; 20(2):653-6. PubMed ID: 19954970
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the protein kinase B signaling pathway.
Woodgett JR
Curr Opin Cell Biol; 2005 Apr; 17(2):150-7. PubMed ID: 15780591
[TBL] [Abstract][Full Text] [Related]
10. Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402.
Dehnhardt CM; Venkatesan AM; Delos Santos E; Chen Z; Santos O; Ayral-Kaloustian S; Brooijmans N; Mallon R; Hollander I; Feldberg L; Lucas J; Chaudhary I; Yu K; Gibbons J; Abraham R; Mansour TS
J Med Chem; 2010 Jan; 53(2):798-810. PubMed ID: 19968288
[TBL] [Abstract][Full Text] [Related]
11. Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates.
Ayral-Kaloustian S; Gu J; Lucas J; Cinque M; Gaydos C; Zask A; Chaudhary I; Wang J; Di L; Young M; Ruppen M; Mansour TS; Gibbons JJ; Yu K
J Med Chem; 2010 Jan; 53(1):452-9. PubMed ID: 19928864
[TBL] [Abstract][Full Text] [Related]
12. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
13. Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling.
van de Laar L; Buitenhuis M; Wensveen FM; Janssen HL; Coffer PJ; Woltman AM
J Immunol; 2010 Jun; 184(12):6600-11. PubMed ID: 20488790
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.
Tietze LF; von Hof JM; Krewer B; Müller M; Major F; Schuster HJ; Schuberth I; Alves F
ChemMedChem; 2008 Dec; 3(12):1946-55. PubMed ID: 19021160
[TBL] [Abstract][Full Text] [Related]
15. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.
Ji J; Zheng PS
Gynecol Oncol; 2010 Apr; 117(1):103-8. PubMed ID: 20102778
[TBL] [Abstract][Full Text] [Related]
16. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
[TBL] [Abstract][Full Text] [Related]
17. SHP-1 sensitizes MCF-7 cells to trichostatin A-induced apoptosis by modulating PI3K-dependent events.
Xu Y; Mousseau DD; Banville D; Zhao X; Shen SH
Cell Death Differ; 2003 Oct; 10(10):1213-4. PubMed ID: 14502244
[No Abstract] [Full Text] [Related]
18. ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines.
Zask A; Verheijen JC; Curran K; Kaplan J; Richard DJ; Nowak P; Malwitz DJ; Brooijmans N; Bard J; Svenson K; Lucas J; Toral-Barza L; Zhang WG; Hollander I; Gibbons JJ; Abraham RT; Ayral-Kaloustian S; Mansour TS; Yu K
J Med Chem; 2009 Aug; 52(16):5013-6. PubMed ID: 19645448
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis.
Xiao C; Yang BF; Song JH; Schulman H; Li L; Hao C
Exp Cell Res; 2005 Mar; 304(1):244-55. PubMed ID: 15707589
[TBL] [Abstract][Full Text] [Related]
20. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.
Palchaudhuri R; Hergenrother PJ
Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
